Benchmark initiated coverage of Kamada (KMDA) with a Buy rating and $15 price target Kamada has expanded its specialty plasma-derived product ...
The TipRanks All-star Analyst of the Day title goes to analyst Harlan Sur of research firm J.P. Morgan. Remarkably, Sur ranks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback